Press Release - Cellfina™ Earns Longest FDA Clearance for a Cellulite Treatment
Aug. 04, 2015



ULTHERA ANNOUNCES TWO YEAR FDA CLEARANCE FOR CELLFINA™ SYSTEM

RALEIGH, N.C. – AUGUST 3, 2015 – BUSINESS WIRE – Ulthera, Inc. a wholly-owned subsidiary of Merz, Inc. (US affiliate of the global Merz Pharma Group), announced today that the U.S. FDA has cleared its Cellfina™ System for the long-term improvement in the appearance of cellulite on the buttocks and thighs with no loss of benefit for up to 2 years.
Click here to read Press Release